SBIR-STTR Award

Long term transcutaneous devices such as catheters; require patients to endure extended skin breaches (wounds) that can be difficult to manage clinically, i.e. infection and inflammation. These complications not only shorten device lifespan, but also compromise patient health. In the case of short-term commercial transcutaneous glucose sensors, FDA has approved their usage for 3-7 days for patients with diabetes. Although infection is an issue with these short-term sensors extending the in vivo lifespan of these sensors from days to weeks increases the risks of adverse effects. Adverse effects seen at sites of glucose sensor implantation include infection, irritation, redness, itching and inflammation. All these adverse effects can and do shorten sensor lifespan in vivo. All these adverse effectives not only compromise sensor function, but also discourage patient involvement in implantable sensors. Clearly, decreasing the risk of infections and inflammation at sensor implantation sites would likely not only increase sensor lifespan, but also decrease associated complications and adverse events. In the present proposal we proposed to develop and validate a number of hydrogel based sensor collars and coatings including one that are bio-enhanced to promote sensor lifespan in vivo. These sensor collars and coatings will be used alone and in combination to extend glucose sensor function in vivo. We believe this approach will usher in a new generation of devices / adjuvants that will enhance the function and extend lifespan of not only existing commercial sensors, but also future generation of trancutaneous glucose sensors.

Public Health Relevance:
Increasing the implantation time frame beyond the FDA approved 3-7 days for transcutaneous glucose sensors increases the risk of adverse effects, such as infection, irritation, redness, itching and inflammation, at sites of sensor implantation and as such decreases sensor lifespan in vivo. In order to avoid these adverse effects we propose to develop and validate a number of hydrogel based sensor collars and coatings including one that are bio-enhanced to promote sensor lifespan in vivo.

Project Terms:
glucose sensor; Longevity; novel strategies

Long term transcutaneous devices such as catheters;require patients to endure extended skin breaches (wounds) that can be difficult to manage clinically, i.e. infection and inflammation. These complications not only shorten device lifespan, but also compromise patient health. In the case of short-term commercial transcutaneous glucose sensors, FDA has approved their usage for 3-7 days for patients with diabetes. Although infection is an issue with these short-term sensors extending the in vivo lifespan of these sensors from days to weeks increases the risks of adverse effects. Adverse effects seen at sites of glucose sensor implantation include infection, irritation, redness, itching and inflammation. All these adverse effects can and do shorten sensor lifespan in vivo. All these adverse effectives not only compromise sensor function, but also discourage patient involvement in implantable sensors. Clearly, decreasing the risk of infections and inflammation at sensor implantation sites would likely not only increase sensor lifespan, but also decrease associated complications and adverse events. In the present proposal we proposed to develop and validate a number of hydrogel based sensor collars and coatings including one that are bio-enhanced to promote sensor lifespan in vivo. These sensor collars and coatings will be used alone and in combination to extend glucose sensor function in vivo. We believe this approach will usher in a new generation of devices / adjuvants that will enhance the function and extend lifespan of not only existing commercial sensors, but also future generation of trancutaneous glucose sensors. , ,

Public Health Relevance:
Increasing the implantation time frame beyond the FDA approved 3-7 days for transcutaneous glucose sensors increases the risk of adverse effects, such as infection, irritation, redness, itching and inflammation, at sites of sensor implantation and as such decreases sensor lifespan in vivo. In order to avoid these adverse effects we propose to develop and validate a number of hydrogel based sensor collars and coatings including one that are bio-enhanced to promote sensor lifespan in vivo.

Thesaurus Terms:
Adjuvant;Adverse Experience;Adverse Effects;Adverse Event;Anthelone U;Antibiotic Agents;Antibiotic Drugs;Antibiotic Therapy;Antibiotic Treatment;Antibiotics;Bactrim;Benzenesulfonamide, 4-Amino-N-(5-Methyl-3-Isoxazolyl)-, Mixt. With 5-((3,4,5-Trimethoxyphenyl)Methyl)-2,4-Pyrimidinediamine;Body Tissues;Catheters;Cellular Expansion;Cellular Growth;Centrin;Chemotaxis;Cotrim;D-Glucose;Data;Defect;Development;Devices;Dextrose;Diabetes Mellitus;Egf;Elements;Epidermal Growth Factor;Epidermal Growth Factor-Urogastrone;Epithelial;Epithelial Cell Proliferation;Epithelial Cells;Eslectin;Evaluation;Fda Approved;Fibrosis;Future Generations;Gfac;Generations;Glucose;Grant;Growth Agents;Growth Factor;Growth Factors, Proteins;Growth Substances;Healed;Health;Human;Human Urinary Gastric Inhibitor;Human, General;Hydrogels;Inflm;Infection;Infection Prevention;Inflammation;Inflammatory Response;Insozalin;Itching;Lead;Length Of Life;Life;Longevity;Mammals, Mice;Man (Taxonomy);Man, Modern;Mice;Miscellaneous Antibiotic;Movement;Murine;Mus;Ndul;Nodule;Nutrient;O Element;O2 Element;Oral;Outcome;Oxygen;Patients;Pb Element;Phagocytosis;Prevent Infection;Pruritic Disorder;Pruritis;Pruritus;Redness;Risk;Role;Smz-Tmp;Site;Skin;Tmp-Smx;Testing;Therapeutic Agents;Time;Tissues;Topical Antibiotic;Treatment Side Effects;Trimedin;Trimethoprim-Sulfamethoxazole;Trimethoprim-Sulfamethoxazole Combination;Trimezole;Ulcn;Ulcer;Ulceration;Urogastrone;Vascular Blood Supply;Wound Healing;Wound Repair;Angiogenesis;Anti-Microbial;Anti-Microbial Agent;Anti-Microbial Drug;Antimicrobial;Antimicrobial Agent;Antimicrobial Drug;Base;Beta-Urogastrone;Blood Supply;Body Movement;Cell Growth;Cost Effective;Design;Designing;Diabetes;Drinking Water;Glucose Sensor;Healing;Heavy Metal Pb;Heavy Metal Lead;Implantation;Implanted Sensor;In Vivo;Irritation;Life Span;Lifespan;Migration;Mouse Model;Neovascularization;New Approaches;Novel Approaches;Novel Strategies;Novel Strategy;Prevent;Preventing;Public Health Relevance;Response;Sensor;Side Effect;Social Role;Therapy Adverse Effect;Tissue Repair;Treatment Adverse Effect;Treatment Of Bacterial Diseases;Treatment Of Bacterial Infectious Disease;Vascular Supply;Wound